107 related articles for article (PubMed ID: 6686449)
21. [Interrelationship between the structure of IGG and its FC-fragment and their ability to react with protein A of Staphylococcus aureus].
Tarkhanova IA; Rudenskiĭ AIu; Sycheva IM; Kul'berg AIa
Biull Eksp Biol Med; 1980 Mar; 89(3):318-20. PubMed ID: 7190041
[TBL] [Abstract][Full Text] [Related]
22. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
23. Efficaciousness of immunoglobulin G prophylaxis on mortality and physiological variables in gram-negative peritonitis in rodents.
Emerson TE; Lurton JM; Collins MS
Circ Shock; 1985; 17(3):213-22. PubMed ID: 3907885
[TBL] [Abstract][Full Text] [Related]
24. IgA, IgM and IgG anti-M. leprae antibodies in babies of leprosy mothers during the first 2 years of life.
Melsom R; Harboe M; Duncan ME
Clin Exp Immunol; 1982 Sep; 49(3):532-42. PubMed ID: 6756719
[TBL] [Abstract][Full Text] [Related]
25. The direct reaction between Salmonella enteritidis endotoxin and antibody. Measurement of 7S and 19S antibody in normal, tolerant and immune sera.
Gupta JD; Reed CE
J Immunol; 1967 May; 98(5):1093-103. PubMed ID: 6024982
[No Abstract] [Full Text] [Related]
26. Anticomplementary activity and the safety of intravenous immunoglobulin.
Rousell RH; Budinger MD; Keppler DC; Victor R; Minaga T
Clin Ther; 1989; 11(1):143-50. PubMed ID: 2497981
[TBL] [Abstract][Full Text] [Related]
27. Staphylococcal protein A simultaneously interacts with framework region 1, complementarity-determining region 2, and framework region 3 on human VH3-encoded Igs.
Potter KN; Li Y; Capra JD
J Immunol; 1996 Oct; 157(7):2982-8. PubMed ID: 8816406
[TBL] [Abstract][Full Text] [Related]
28. [Determination of the antibody class in Leptospira infection].
Stoianova NA; Khazenson SL
Lab Delo; 1981; (3):174-6. PubMed ID: 6164838
[No Abstract] [Full Text] [Related]
29. On the mutagenicity and immunogenicity of a beta-propiolactone-treated therapeutic IgG-preparation.
Pincus JH; Mortelmans K; Tanaka W; Stephan W; Lissner R
Arzneimittelforschung; 1981; 31(11):1924-8. PubMed ID: 6172136
[TBL] [Abstract][Full Text] [Related]
30. S-sulfonation: a reversible chemical modification of human immunoglobulins permitting intravenous application. I. Physicochemical and binding properties of S-sulfonated and reconstituted IgG.
Gronski P; Hofstaetter T; Kanzy EJ; Lüben G; Seiler FR
Vox Sang; 1983; 45(2):144-54. PubMed ID: 6604365
[TBL] [Abstract][Full Text] [Related]
31. Molecular structure alteration of IgG increased anticomplementary activity of intravenous immunoglobulin.
Zang XX; Sun Y; Shen F; Wang D; Zhou L; Wang J; Kung E
Zhongguo Yao Li Xue Bao; 1995 Sep; 16(5):415-9. PubMed ID: 8701757
[TBL] [Abstract][Full Text] [Related]
32. A new liquid, intravenous immunoglobulin product (IGIV 10%) highly purified by a state-of-the-art process.
Teschner W; Butterweck HA; Auer W; Muchitsch EM; Weber A; Liu SL; Wah PS; Schwarz HP
Vox Sang; 2007 Jan; 92(1):42-55. PubMed ID: 17181590
[TBL] [Abstract][Full Text] [Related]
33. Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor.
Quigg RJ; Kozono Y; Berthiaume D; Lim A; Salant DJ; Weinfeld A; Griffin P; Kremmer E; Holers VM
J Immunol; 1998 May; 160(9):4553-60. PubMed ID: 9574562
[TBL] [Abstract][Full Text] [Related]
34. [The application of immunoperoxidase test for the detection of antibodies various classes (IgA, IgG and IgM) coating bacteria in urine].
Jakoniuk P; Leszczyńska K; Zalewska M; Sacha P; Wieczorek P
Med Dosw Mikrobiol; 2005; 57(4):431-6. PubMed ID: 16773837
[TBL] [Abstract][Full Text] [Related]
35. Activation of effector functions by immune complexes of mouse IgG2a with isotype-specific autoantibodies.
Rajnavölgyi E; Fazekas G; Lund J; Daeron M; Teillaud JL; Jefferis R; Fridman WH; Gergely J
Immunology; 1995 Apr; 84(4):645-52. PubMed ID: 7540592
[TBL] [Abstract][Full Text] [Related]
36. Molecular selection of human antibodies with an unconventional bacterial B cell antigen.
Sasano M; Burton DR; Silverman GJ
J Immunol; 1993 Nov; 151(10):5822-39. PubMed ID: 8228264
[TBL] [Abstract][Full Text] [Related]
37. Radioimmunoassay for the detection of antigen-specific IgM, IgG, and IgA in equine sera.
Rearden TP; Sprouse RF; Garner HE
Am J Vet Res; 1982 Feb; 43(2):294-8. PubMed ID: 7046535
[TBL] [Abstract][Full Text] [Related]
38. Comparison of antibody activity against various microorganisms in intravenous immunoglobulin preparations determined by ELISA and opsonic assay.
Hiemstra PS; Brands-Tajouiti J; van Furth R
J Lab Clin Med; 1994 Feb; 123(2):241-6. PubMed ID: 8301200
[TBL] [Abstract][Full Text] [Related]
39. A model for the formation and interconversion of protein A-immunoglobulin G soluble complexes.
Hanson DC; Schumaker VN
J Immunol; 1984 Mar; 132(3):1397-409. PubMed ID: 6693770
[TBL] [Abstract][Full Text] [Related]
40. Immunoglobulin class specific antibodies to M. leprae in leprosy patients, including the indeterminate group and healthy contacts as a step in the development of methods for sero-diagnosis of leprosy.
Melsom R; Harboe M; Myrvang B; Godal T; Belehu A
Clin Exp Immunol; 1982 Feb; 47(2):225-33. PubMed ID: 7042137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
